About Me:
Head, Department of Neurology In-charge of Parkinson’s Disease and Movement Disorders Program Director, RGCM Research Center, India. Vice Chairman, Institute of Neurosciences Kolkata 185/1 AJC Bose Road, Kolkata 700017. Secretary, Movement Disorders Society of India (2021-2023). Treasurer, Movement Disorders Society of India (2019-2021). Member, Education Committee; Movement Disorders Society- AOS. Chief Editor, Movement Disorders in Clinical Practice (Indian Edition). Editor, Headache (Indian edition). Founder President, Parkinson's Disease Patient Welfare Society of Kolkata (PDPWSK); Spinocerebellar Ataxia-12 (SCA 12) Consortium.
Prof. Hrishikesh Kumar
MD (Medicine), DM (Neurology), DCN (London, UK), Fellow, Movement Disorders (UWO, Canada) Vice Chairman, Director of Research, HOD Neurology
Emergency Cases
HONORS
- Secretary, Movement Disorder Society of India
- Elected as MDS-AOS Education Committee member for 2019-2021 term
- Bishista Chikitsha Samman from Govt of West Bengal in 2019
- Selected for India Academy of Neurology Queen Square fellowship (2006-2007)
- Received Patricia Harris award for best studentship (2006-2007)
GRANTS RECEIVED:
1. EMBO Short-Term Fellowship
Funding agency: European Molecular Biology Organization (EMBO)
Reference number:EMBO Short-Term Fellowship- 8574 Project Title:High frequency cortico-muscular coherence during strong hand grip in healthy human
Year received: 2019-2020
Reference number:EMBO Short-Term Fellowship- 8574 Project Title:High frequency cortico-muscular coherence during strong hand grip in healthy human
Year received: 2019-2020
2. DST Inspire Fellowship- Joint supervisor of Jyoti Rungta:
Funding agency: Department of Science and Technology, Govt of India
Project Title:Insight into disease pathogenesis of Spinocerebellar Ataxia (SCA)-12: A cellular and therapeutic approach.
Year received: 2021
Project Title:Insight into disease pathogenesis of Spinocerebellar Ataxia (SCA)-12: A cellular and therapeutic approach.
Year received: 2021
3. Newton Bhabha PhD Placement Fellowship 2020-21- Joint supervisor of Akash Roy:
Funding agency: Department of Science and Technology, Govt of India & British Council, UK
Project Title:Drug Repurposing to re-activate impaired mitophagy: A novel approach towards therapeutics of Parkinson’s Disease. Year received: 2020-21
Year received: 2020
Project Title:Drug Repurposing to re-activate impaired mitophagy: A novel approach towards therapeutics of Parkinson’s Disease. Year received: 2020-21
Year received: 2020
4. Indian Academy of Neurology Research Grant Scheme-2020.
Funding agency: The Indian Academy of Neurology Research Grant Scheme
Project Title: “ Effect of Noninvasive Cervical Vagus Nerve Stimulation on Levodopa Induced Dyskinesia - A Crossover Randomized Controlled Trial”
Year received: 2020
Project Title: “ Effect of Noninvasive Cervical Vagus Nerve Stimulation on Levodopa Induced Dyskinesia - A Crossover Randomized Controlled Trial”
Year received: 2020
5. DST WOS-A fellowship - Mentor of Banashree Mondal:
Funding agency: Department of Science and Technology, Govt of India
Women Scientist Scheme A from DST, India
Project Title: “ Effect of Non-Invasive Vagus Nerve Stimulation in Oxidative Stress and Freezing of Gait in Parkinson’s Disease Patients
Year received: 2018
Project Title: “ Effect of Non-Invasive Vagus Nerve Stimulation in Oxidative Stress and Freezing of Gait in Parkinson’s Disease Patients
Year received: 2018
6. DST Inspire Fellowship- Joint supervisor of Akash Roy:
Funding agency: Department of Science and Technology, Govt of India
Project Title: Biomarkers of Parkinson’s disease: A Translational Approach and Identification of its clinical implications
Year received: 2017
Project Title: Biomarkers of Parkinson’s disease: A Translational Approach and Identification of its clinical implications
Year received: 2017
7. Co investigator in Prof Stuart Bakers grant:
Funding agency: MRC Concept Grant
Project Title: Stop Signal Reaction Time in movement disorders
Year received: 2019-20
Project Title: Stop Signal Reaction Time in movement disorders
Year received: 2019-20
8. Genome Wide Association Study:
Funding agency: One of the Centre of a multicentre study funded by MJ Fox Foundation
Project Title: Genome Wide Association Study in Parkinson’s Disease
Year received: 2019
Project Title: Genome Wide Association Study in Parkinson’s Disease
Year received: 2019
Clinical Trials
Funding agency: NOVARTIS
Project Title: A prospective, 16 week, phase IV study to evaluate safety, tolerability and effectiveness in patients with severe dementia of the Alzheimer’s type exposed to rivastigmine (Exelon) 15 cm2 transdermal patch
Year received: 2021
Project Title: A prospective, 16 week, phase IV study to evaluate safety, tolerability and effectiveness in patients with severe dementia of the Alzheimer’s type exposed to rivastigmine (Exelon) 15 cm2 transdermal patch
Year received: 2021
Funding agency: KASHIV BIOSCIENCES LLC, USA
Project Title: An open-label, parallel, single ascending dose (SAD) study investigating the pharmacokinetics, dose proportionality, and safety of K102 in patients with Parkinson’s disease (PD).
Year received: 2020
Project Title: An open-label, parallel, single ascending dose (SAD) study investigating the pharmacokinetics, dose proportionality, and safety of K102 in patients with Parkinson’s disease (PD).
Year received: 2020
Funding agency: Pharmazz India Pvt. Ltd
Project Title: A Prospective, Multi-Centric, Randomized, Double-Blind, Parallel, Phase-III Clinical Study to Assess Efficacy of PMZ-1620 along with Standard Treatment in Patients of Acute Ischemic Stroke.
Year received: 2020
Project Title: A Prospective, Multi-Centric, Randomized, Double-Blind, Parallel, Phase-III Clinical Study to Assess Efficacy of PMZ-1620 along with Standard Treatment in Patients of Acute Ischemic Stroke.
Year received: 2020
Funding agency: Macleods Pharmaceuticals Ltd
Project Title: A Prospective, Randomized, Double-blind, Placebo-Controlled Proof-of-concept to study the clinical efficacy and safety of L-seriene supplement along with standard treatment in Patients with Alzheimer’s Disease
Year received: 2020
Project Title: A Prospective, Randomized, Double-blind, Placebo-Controlled Proof-of-concept to study the clinical efficacy and safety of L-seriene supplement along with standard treatment in Patients with Alzheimer’s Disease
Year received: 2020
Funding agency: Novartis Healthcare Pvt Ltd (NHPL)
Project Title:A 12-week double-blind, randomized, multi-center study comparing the efficacy and safety of once monthly subcutaneous AMG 334 against placebo in adult episodic migraine patients (EMPOwER).
Year received: 2019
Project Title:A 12-week double-blind, randomized, multi-center study comparing the efficacy and safety of once monthly subcutaneous AMG 334 against placebo in adult episodic migraine patients (EMPOwER).
Year received: 2019
Funding agency: Bioxcel Corporation US & India
Project Title:A Randomized, Blinded, Prospective, Placebo Controlled, Investigator Initiated Study to Evaluate Efficacy and Safety of Dexmedetomidine Injection in the agitated subjects with Mild Probable Alzheimer’s Disease.
Year received: 2018
Project Title:A Randomized, Blinded, Prospective, Placebo Controlled, Investigator Initiated Study to Evaluate Efficacy and Safety of Dexmedetomidine Injection in the agitated subjects with Mild Probable Alzheimer’s Disease.
Year received: 2018
Funding agency: AstraZeneca Pharmaceutical Company
Project Title:A Randomised, Double-Blind, Placebo-Controlled, International, Multicentre, Phase III Study to Investigate the Efficacy and Safety of Ticagrelor and ASA Compared with ASA in the Prevention of Stroke and Death in Patients with Acute Ischaemic Stroke or Transient Ischaemic Attack
Year received: 2018
Project Title:A Randomised, Double-Blind, Placebo-Controlled, International, Multicentre, Phase III Study to Investigate the Efficacy and Safety of Ticagrelor and ASA Compared with ASA in the Prevention of Stroke and Death in Patients with Acute Ischaemic Stroke or Transient Ischaemic Attack
Year received: 2018
SOCIAL INTERACTIONS
- Delivered various talksfor the awareness of Parkinson’s disease at various NGOs & clubs like Bengal Rowing Club, LION’s club, Rotary club etc.
- Under the umbrella of I-NK, clinicians and researchers of the institute have started a society for welfare of patients with Parkinson's Disease and for their care-givers. We organize weekly program at two centers of Kolkata (one each in North and South). The program is aimed to foster camaraderie among patients and their care givers. It gives them a platform where they share their joy and sorrow. The program is monitored by trained professionals who teach patients and their care-givers about the various aspects of living with Parkinson's Disease and includes sessions of physiotherapy, dance therapy, psychological support. Renowned dancer Mrs. Alakanada Roy is regularly helping us in incorporating dance movements as a part of rehabilitation in patients with Parkinson's Disease.
- I-NK organizes a larger monthly program in its seminar hall where clinicians, rehab specialists and psychologists mingle with patients and their care-givers in a semi-formal setting. Every month we have participation of more than 100 patients and care-givers. These programs invigorate the patients and their family members and provide them zeal to live well and with optimism.
- I-NK also organizes yearly program on World Parkinson's Disease day on the 11th of April every year. Apart from patients and care-givers people, from various strata of society participate in the program.
- The patients of PD attending the clinics at I-NK have formed a cultural and choir group and they perform at various functions regularly.
- Every year PD patients coming to I-NK along with the doctors participate in Tata Steel marathon to create awareness about the disease in general public.
